Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

Hepatology

Volumn 27, Issue 3, 1998, Pages 881-886

  Keeffe, Emmet B ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGED; ANOREXIA; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOGENICITY; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FEMALE; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HEPATITIS B; HEPATITIS C; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VACCINATION; VIRAL HEPATITIS VACCINES;

EID: 0031915859     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270336     Document Type: Article

References (14)

1. Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D. Relapsing hepatitis A: review of 14 cases and literature survey. Medicine 1992;71:14-23.
2. Schiff ER. Atypical clinical manifestations of hepatitis A, Vaccine 1992;10(suppl 1):18S-20S.
3. Wagstaff AJ, Plosker GL, Balfour J. Inactivated hepatitis A vaccine (HM175 Strain): a preliminary review of its immunogenicity, protective potential and tolerability in at-risk patients. Clin Immunother 1996;6:68-88.
4. Dienstag JL, Isselbacher KJ. Acute Hepatitis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. Vol. 2. Ed. 13. New York:McGraw-HilI, 1994:1458-1477.
5. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995;90:201-205.
6. Hadler SC. Global impact of hepatitis A virus infection changing patterns. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1990:14-20.
7. Yao G. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991:14-20.
8. Fukumoto Y, Okita K, Konishi T, Takemoto T. Hepatitis A infection in chronic carriers of hepatitis B virus. In: Sung J-L, Chen D-S, eds. Viral Hepatitis and Hepatocellular Carcinoma. Amsterdam: Excerpta Medica, 1990:43-48.
9. Conteas C, Kao H, Rakela J, Weliky B. Acute type A hepatitis in three patients with chronic HBV infection. Dig Dis Sci 1983;28:684-686.
10. Viola LA, Barrison IG, Coleman JC, Murray-Lyon IM. The clinical course of acute type A hepatitis in chronic HBsAg carriers - a report of 3 cases. Postgrad Med J 1982;58:80-81.
11. Zachoval R, Roggendorf M, Deinhardt E Hepatitis A infection in chronic carriers of hepatitis B virus. HEPATOLOGY 1983;3:528-531.
12. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntaykorn S, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328-1334.
13. Riedemann S, Reinhardt G, Frösner GG, Ibarra H, Moraleda L, Hering V, Siegel F, et al. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile. Vaccine 1992;10(suppl 1):S152-S155.
14. McMahon BJ, Williams J, Bulkow L, Snowball M, Wainwright R, Kennedy M, Krause D. Immunogenicity of an inactivated hepatitis A vaccine in Alaska native children and native and non-native adults. J Infect Dis 1995;171:676-679.